News
Tool-Temp AG acquires 100 percent of the shares of its United States-based branch as part of a strategic move for ...
Sujay Jadhav, CEO of Verana Health, spoke with Pharmaceutical Executive about how external control arms (ECAs) are impacting clinical trials and improving the entire process. Pharmaceutical Executive: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback